These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28864365)

  • 1. Diabetes-Related Dyslipidemia and Cardiovascular Events.
    Fonseca VA; Lovre D
    Am J Med Sci; 2017 Aug; 354(2):103-104. PubMed ID: 28864365
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ; Lundman P; Tardif JC
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Bilz S
    Ther Umsch; 2017; 74(8):445-453. PubMed ID: 29461147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment: 9. Dyslipidemia].
    Arai H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):890-4. PubMed ID: 23772503
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statins and the risk of diabetes].
    Simonyi G
    Orv Hetil; 2013 Oct; 154(43):1691-5. PubMed ID: 24140507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.
    Lovre D; Shah S; Sihota A; Fonseca VA
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):237-257. PubMed ID: 29407054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglycerides and HDL cholesterol: stars or second leads in diabetes?
    Bitzur R; Cohen H; Kamari Y; Shaish A; Harats D
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S373-7. PubMed ID: 19875584
    [No Abstract]   [Full Text] [Related]  

  • 8. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.
    Gonzalez GL; Manrique CM; Sowers JR
    J Cardiometab Syndr; 2006; 1(3):178-83. PubMed ID: 17679817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of dyslipidemia in patients with diabetes mellitus.
    Pikto-Pietkiewicz W; Wołkowska K; Pasierski T
    Pharmacol Rep; 2005; 57 Suppl():10-9. PubMed ID: 16415483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.
    Chen SC; Tseng CH
    Rev Diabet Stud; 2013; 10(2-3):88-100. PubMed ID: 24380085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination lipid therapy in type 2 diabetes mellitus.
    Vergès B
    Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Verma S; Leiter LA; Mazer CD; Bain SC; Buse J; Marso S; Nauck M; Zinman B; Bosch-Traberg H; Rasmussen S; Michelsen MM; Bhatt DL
    Circulation; 2018 Oct; 138(15):1605-1607. PubMed ID: 30354517
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic dyslipidemia and response to intensified glycemic treatment: why there are differences?
    Baroni MG
    J Endocrinol Invest; 2005 Nov; 28(10):869-70. PubMed ID: 16419487
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose and LDL lowering: the need for intensive therapy.
    Del Prato S
    Curr Vasc Pharmacol; 2012 Nov; 10(6):687-9. PubMed ID: 23259554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and lipid management in diabetes.
    Jaiswal M; Schinske A; Pop-Busui R
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):325-38. PubMed ID: 24840262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using apolipoprotein B to manage dyslipidemic patients: time for a change?
    Harper CR; Jacobson TA
    Mayo Clin Proc; 2010 May; 85(5):440-5. PubMed ID: 20435837
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of dyslipidemia in diabetes.
    Solano MP; Goldberg RB
    Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.